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ABSTRACT Productivity of bacterial cell factories is frequently compromised by
stresses imposed by recombinant protein synthesis and carbon-to-product conver-
sion, but little is known about these bioprocesses at a systems level. Production of
the unnatural metabolite citramalate in Escherichia coli requires the expression of a
single gene coding for citramalate synthase. Multiomic analyses of a fermentation
producing 25 g liter1 citramalate were undertaken to uncover the reasons for its
productivity. Metabolite, transcript, protein, and lipid proﬁles of high-cell-density,
fed-batch fermentations of E. coli expressing either citramalate synthase or an inacti-
vated enzyme were similar. Both fermentations showed downregulation of ﬂagellar
genes and upregulation of chaperones IbpA and IbpB, indicating that these re-
sponses were due to recombinant protein synthesis and not citramalate production.
Citramalate production did not perturb metabolite pools, except for an increased in-
tracellular pyruvate pool. Gene expression changes in response to citramalate were
limited; none of the general stress response regulons were activated. Modeling of
transcription factor activities suggested that citramalate invoked a GadW-mediated
acid response, and changes in GadY and RprA regulatory small RNA (sRNA) expres-
sion supported this. Although changes in membrane lipid composition were ob-
served, none were unique to citramalate production. This systems analysis of the
citramalate fermentation shows that E. coli has capacity to readily adjust to the
redirection of resources toward recombinant protein and citramalate production,
suggesting that it is an excellent chassis choice for manufacturing organic acids.
IMPORTANCE Citramalate is an attractive biotechnology target because it is a pre-
cursor of methylmethacrylate, which is used to manufacture Perspex and other high-
value products. Engineered E. coli strains are able to produce high titers of citra-
malate, despite having to express a foreign enzyme and tolerate the presence of a
nonnative biochemical. A systems analysis of the citramalate fermentation was un-
dertaken to uncover the reasons underpinning its productivity. This showed that E.
coli readily adjusts to the redirection of metabolic resources toward recombinant
protein and citramalate production and suggests that E. coli is an excellent chassis
for manufacturing similar small, polar, foreign molecules.
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Citramalic acid can be used as a chemical precursor to methylmethacrylate (MMA [1,2]), a relatively high-value bulk chemical with a wide range of applications, includ-
ing the manufacture of Perspex. High-titer bioproduction of citramalate to 82 g
liter1 has been developed simply by expressing an evolved Methanococcus jannaschii
citramalate synthase (CimA3.7 [3]) in Escherichia coli to catalyze the reaction of pyruvate
and acetyl coenzyme A (acetyl-CoA) to produce citramalate (4, 5). Although some minor
by-products can be formed in the fed-batch fermentation process, these can be
converted to MAA alongside the citramalate in the chemical conversion process (2, 5).
Further work to eliminate their formation using chassis gene deletions (ackA-pta, aceB,
glcB, gltA, leuCD, and poxB) resulted in much lower yields of citramalate (6–8) and
increased process costs (5). This prior work has demonstrated the potential to develop
bio-based production of citramalate in a simple fed-batch process using a minimally
engineered E. coli strain as a precursor for manufacturing MMA.
The product titers are surprising given that citramalate is not formed naturally by E.
coli and that citramalate formation drains two central metabolites—pyruvate and
acetyl-CoA. Therefore, time-resolved multiomic analyses (transcriptome, proteome,
metabolome, and lipidome) of the citramalate fermentation were undertaken to un-
derstand the effects of both recombinant protein synthesis (CimA3.7) and citramalate
production on the host E. coli chassis. Citramalate production had relatively few effects
on the host transcriptome, proteome, lipidome, or metabolome, providing a simple
explanation for the exceptional product titers and yields.
RESULTS AND DISCUSSION
Citramalate production and multiomic sampling regime in a high-cell-density,
fed-batch fermentation. Escherichia coli expressing citramalate synthase (CimA3.7) or
an inactivated variant (CimA3.7dead) was grown in triplicate, high-cell-density, glucose-
limited fed-batch cultures under aerobic conditions. Preliminary batch culture experi-
ments showed that, after induction with arabinose, CimA3.7dead was produced to
similar levels (4% of total protein) to CimA3.7 and that CimA3.7dead lacked catalytic
activity (see Fig. S1 in the supplemental material). The triplicate control and test
fermentations were reproducible, such that the data could be combined (Fig. 1). After
initial batch growth for 18.5 h, the bioprocess continued under a fed-batch regimen,
and synthesis of inactive or active CimA3.7 was induced with L-arabinose at an optical
density at 600 nm (OD600) of 50. The subsequent feeding regimen was implemented
to produce citramalate concentrations close to the 50% effective concentration
(EC50 [173  7 mM]) (5). For subsequent analyses, samples were obtained before
induction (S1) and then 4 h (S2) and 21.5 h (S3) postinduction for triplicate control
(C [CimA3.7dead]) and test (T [CimA3.7]) fermentations (Fig. 1).
Both control and test fermentations consumed all the glucose provided in the
culture feed, with higher biomass production in the control compared to the test
(conversion efﬁciencies for biomass with glucose of 0.30  0.01 g cell dry weight [cdw]
g glucose1 for the controls and 0.26  0.01 g cdw g glucose1 for the test fermen-
tations [Fig. 1]). As expected, the major difference was the accumulation of citramalate
to 153  5 mM in the test fermentations, which equates to 0.129  0.003 mol
citramalate per mol glucose consumed (Fig. 1B). After induction, the control fermen-
tations produced low concentrations of formate (3 mM) and acetate (maximally
1.7 mM). Acetate, but not formate, was also detected (maximally 1.1 mM) in the test
fermentations.
Proton nuclear magnetic resonance (NMR) of culture supernatants conﬁrmed that
citramalate was the dominant exo-metabolite in the test fermentations, along with
30-fold-lower concentrations of citraconate (see Fig. S2 in the supplemental material).
The overall carbon recoveries (assuming that 1 g of biomass corresponds to the
production of 1 g of CO2) were 85%  2%, 81%  5%, and 67%  4% for control
sample 1 [CS1], CS2, and CS3, respectively, and 91%  6%, 83%  2%, and 73%  3%
for test sample 1 [TS1], TS2, and TS3, respectively (Fig. 1). A multiomic approach was
taken to enhance understanding of the mechanisms underpinning adaptation to
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recombinant protein/product accumulation in high-cell density fermentations at a
system level.
To investigate cellular adaptations to production of citramalate, samples of the
citramalate production fermentation were taken at representative time points before
and after induction of CimA3.7 or CimA3.7dead. Samples were used for comprehensive
multiomic analyses of mRNA, protein, lipid and metabolite levels.
Citramalate production results in an increased intracellular pyruvate pool.
Before induction of CimA, the control and test fermentation endo-metabolomes were
similar, clustering together in principal-component analysis (PCA) plots (Fig. 2). After
induction, the endo-metabolomes of the control and test fermentations were clearly
differentiated by citramalate (bin mass of 148.08 Da) (Fig. 2A). Reanalysis of these data
after removal of the citramalate and phosphate mass bins revealed further differences
between the control and test fermentations after induction (Fig. 2B). These included bin
masses of 88.05 Da (identiﬁed as pyruvate by tandem mass spectrometry [MS-MS]),
130.08 Da (citraconic acid), 149.08 Da (possibly methionine), and 162.08 Da (2-
ethylmalate). Citraconic acid is formed from citramalate by the E. coli 3-isopropylmalate
dehydratase LeuCD (Fig. 2C) (3). However, previous attempts to remove this activity via
individual leuC and leuD mutations increased fermentation cost and complexity
through the requirement to feed leucine and did not enhance citramalate production
in shake ﬂask cultures (7). In an industrial process, citraconate is not problematic since
it can be converted to methacrylic acid using the same process as that developed for
citramalate (4, 5). However, the formation of 2-ethylmalate was unexpected, but
resolved by ﬁnding novel activity of CimA3.7 when 2-oxobutyrate was supplied in place
of the cognate substrate, pyruvate, in vitro (see Fig. S3 in the supplemental material).
Hence, 2-ethylmalate was formed by CimA3.7-catalyzed condensation of acetyl-CoA
with 2-oxobutyrate (Fig. 2C). 2-Oxobutyrate can be formed via the citramalate
pathway catalyzed by CimA and LeuBCD or in reactions catalyzed by threonine
deaminase and O-succinylhomoserine lyase (Fig. 2C). Although relatively low, the
intracellular concentration of 2-ethylmalate was 1.7-fold greater than the con-
FIG 1 Fed-batch cultures of E. coli expressing inactivated (A) and active (B) CimA3.7. Biomass (triangles),
glucose consumed (diamonds), citramalate produced (squares), and sampling points (C indicates control,
inactivated CimA3.7dead; T indicates test, active CimA3.7) for omic analyses are indicated. Sample points
CS1 and TS1 are immediately before induction of inactive CimA3.7dead protein or active CimA3.7,
respectively, with L-arabinose.
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FIG 2 Perturbation of chassis metabolites during production of citramalate. (A) Principal-component analysis (PCA) score
plots showing the ﬁrst and second principal components of the endo-metabolome for CS1 to 3 (ﬁlled squares, circles, and
triangles) and TS1 to 3 (open squares, circles, and triangles). The analysis is of three independent biological replicates. (B)
Reanalysis of the endo-metabolome without citramalate and phosphate. (C) Pyruvate generated from the glucose feed by
glycolysis is converted to acetyl-CoA and CO2 by the pyruvate dehydrogenase complex (PDHC). ESI-TOF MS data of the
endo-metabolome suggested that citramalate is efﬁciently produced and accumulates in the cytoplasm (maximum mean
intensity of 6,000) by the action of CimA3.7 on pyruvate and acetyl-CoA, regenerating CoASH. The accumulated
citramalate is mostly excreted (150 mM in the culture medium), but some is converted to citraconate (maximum mean
intensity of 300), catalyzed by isopropylmalate isomerase (LeuCD), and is detected in both the endo- and exo-
metabolome (3 mM in the culture medium) at low levels. Citraconate can be converted to 2-oxobutyrate (maximum
mean intensity of 50) by the combined action of LeuBCD. 2-Oxobutyrate can also be synthesized by the action
of threonine dehydratase or O-succinylhomoserine lyase (MetB). 2-Oxobutyrate is a substrate for CimA3.7, yielding
2-ethylmalate (maximum mean intensity of 800).
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centration of pyruvate. Production of 2-ethylmalate represents an additional drain
on acetyl-CoA pools, reducing the availability of acetyl-CoA for citramalate produc-
tion. Possible interventions to limit production of the 2-ethylmalate by-product
would be deletion of 3-isopropylmalate dehydratase, threonine deaminase, and
O-succinylhomoserine lyase activities or improve the substrate speciﬁcity of CimA3.7.
However, it should be noted that 2-ethylmalate is not detectable in the culture
supernatant and would not, therefore, affect the purity of the citramalate product.
Furthermore, elimination of these 2-ethylmalate-forming reactions would require ex-
pensive nutritional supplementation to compensate for the ensuing auxotrophy (5).
Therefore, further metabolic engineering to eliminate 2-ethylmalate would not provide
any beneﬁts.
The clear differences between the endo-metabolome of the test fermentations
postinduction compared to the controls suggested that there are changes that extend
beyond simply redirecting pyruvate and acetyl-CoA away from aerobic respiratory
metabolism and biomass production toward citramalate synthesis, including the intra-
cellular production of 2-ethylmalate. Therefore, changes in the chassis transcriptome,
proteome, and lipidome during control and test fermentations were analyzed for
responses to the metabolic burdens imposed by heterologous protein synthesis and
citramalate production.
Expression of recombinant citramalate synthase affects gene expression more
than the production of citramalate. The transcriptional response to CimA3.7 and
citramalate production was analyzed. In the control fermentation, 303 genes exhibited
altered transcription (2-fold, adjusted P value of 0.05), 4 h after induction of
CimA3.7dead synthesis and 36 genes after 21.5 h, representing a total of 316 genes (see
Table S1A and Fig. S4 in the supplemental material). For the control fermentations, only
genes linked to ﬂagellar biosynthesis were identiﬁed as being signiﬁcantly enriched
(GO:0071978; 7.79, P  0.024, Fisher’s exact test with false-discovery rate [FDR]
multiple-test correction) by the AmiGO gene ontology software (9). For the test
fermentations, only 15 genes met the signiﬁcance criteria 4 h after induction and 42
genes 21.5 h postinduction, representing a total of 53 different genes, of which 39 were
also differentially regulated in the control (Table S1B). As observed for the control
fermentations, ﬂagellar genes were signiﬁcantly enriched (GO:0071978; 29.02, P 
0.0007) in the test fermentations, suggesting that downregulation of ﬂagellar biosyn-
thesis is an adaptation to high-cell density recombinant protein production. Down-
regulation of ﬂagellar synthesis has been observed during recombinant protein syn-
thesis in other E. coli strains, and it has been suggested that chassis performance might
be enhanced by shutting down the ﬂagellar machinery (10–13).
Genes that were only upregulated in the test fermentations were deemed to be
potentially speciﬁc responses to citramalate production (Table 1). These included two
efﬂux pumps (alaE and mdtE) and components of the E. coli acid response (gadC and
hdeB). This suggested that citramalate production was associated with acid stress and
that AlaE and/or MdtE might contribute to efﬂux of citramalate from the cytoplasm.
TABLE 1 Differentially regulated operons after induction of test fermentations expressing
active CimA3.7 and producing citramalatea
Gene or
operon Function
Maximum
fold change
Direction of
regulation
mdtEF-tolC Multidrug resistance
efﬂux transporter
4.6 Up
malEFG Maltose transport 3.1 Down
gadBC Acid resistance 2.3 Up
treBC EnzIITre PTS; trehalase
6-P hydrolase
2.3 Down
entCABEH Enterobactin synthesis 2.3 Up
hdeAB-yhiD Acid resistance 2.1 Up
alaE L-Alanine export 2.0 Up
aFold change is for the ﬁrst gene in the operon unless indicated otherwise by boldface type.
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The global gene expression data described above suggested that the transcriptional
response to citramalate synthesis was limited. To complement that analysis, the TFInfer
software was used to infer any changes in the activities of 201 regulators during the
control and test fermentations (14). The statistical inference of changes in the activities
of transcription factors has the potential to extract hidden information in the transcrip-
tomic data by revealing the regulators (and by extension their cognate signals) respon-
sible for the observed changes in transcript abundance. This probabilistic approach
requires a connectivity matrix linking transcription factors to transcription units, and
this was constructed using the list of E. coli transcription factors and the operons that
they regulate in RegulonDB (15).
The transcription factors exhibiting the greatest changes in activity (signal/noise
ratio of 4) in the control fermentations were AraC, BirA, ExuR, FlhDC, and PurR (Fig. 3A
and C; see Table S2 in the supplemental material). For the test fermentations, ﬁve
transcription factors, including BirA and FlhDC (BirA, FlhDC, GadW, MalT, PaaX, and
PuuR), responded with a signal-to-noise ratio of 4 (Fig. 3B and C; Table S2). The TFInfer
software also reveals the target genes that are most heavily inﬂuenced by each
transcription factor (Table S2). These analyses further conﬁrm that inactivation of FlhDC
and the consequent inhibition of ﬂagellar gene expression are a core adaptation to
recombinant protein production and that citramalate production initiates a GadW-
mediated acid response and modulation of MalT-regulated sugar uptake. The latter is
notable because enhanced succinate production by E. coli strain HX024, an evolved
derivative of strain Suc-T110, was associated with increased expression of the malK-
lamB-malM operon (16). Thus, changes in MalT-mediated regulation might be a com-
mon response to the production of organic acids using an E. coli chassis. Nevertheless,
none of the major stress-responsive transcription factors (e.g., cyclic AMP receptor
FIG 3 Changes in transcription factor activities inferred from transcriptomic data. The TFInfer software (14) was
used to identify transcription factors that exhibited a signiﬁcant change in activity (signal/noise ratio of 4) upon
induction of control and test fermentations. Induction of the control fermentations resulted in the production of
Cim3.7dead; induction of test fermentations caused the synthesis of CimA3.7 and the consequent accumulation of
citramalate. The cultures were sampled before (S1) and 4 (S2) and 21.5 (S3) h after induction. (A) Transcription
factors that only met the signiﬁcance criteria in the control fermentations. (B) Transcription factors that only met
the signiﬁcance criteria in the test fermentations. (C) Transcription factors that exhibited altered activity after
induction in both the control and the test fermentations. Transcription factors can be identiﬁed by reference to the
keys provided in each panel. The error bars are the standard deviation provided by the posterior distribution.
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protein [CRP], glucose starvation; fumarate and nitrate reductase [FNR], oxygen star-
vation; OxyR/SoxRS, oxidative stress; CpxAR, envelope stress; CspA, cold shock; EvgSA/
PhoPQ/GadE/GadX/EnvZ-OmpR, low pH; NhaR, sodium stress; LexA, DNA damage;
CusR/CueR/Fur/Zur/ZntR, metal ion homeostasis) were signiﬁcantly activated in re-
sponse to CimA3.7dead/CimA3.7 and/or citramalate production.
An alternative analytical approach is to calculate the differences in transcript abun-
dance between the samples CS2 and TS2 and CS3 and TS3 after normalization to the
respective preinduction samples CS1 and TS1 (Fig. 1). The data were then ﬁltered to
include transcripts exhibiting differences in abundance of 2-fold (adjusted P value of
0.05) in the test samples compared to the control (Table S1C). These criteria were met
by only seven genes: two associated with sulfur metabolism (cysD and cysW), two with
transporter functions (exuT and malK-lamB-malM), one coding for a hypothetical pro-
tein (ygbK), and genes associated with ﬂagellar (fliA) and tryptophan (trpD) biosynthesis
(Table 2). Despite the diversion of pyruvate and acetyl-CoA away from central metab-
olism toward citramalate production and the potential for citramalate-induced osmotic
stress in the postinduction production cultures, extensive changes in gene expression
were not observed (Table S1C).
Roles of sRNAs during citramalate production. As well as permitting changes in
the expression of mRNAs to be detected, the microarray design included 132 custom
probes to report on the abundances of 77 noncoding RNAs. The abundances of 13
small regulatory RNAs (sRNAs) changed signiﬁcantly upon induction of CimA3.7 (Ta-
ble 3). Three of these sRNAs (ChiX, RyhB, and RyjA) were regulated similarly in the
control and citramalate production fermentations. Increased abundance of ChiX results
in inhibition of chitosugar uptake and utilization, enhanced levels of RyhB are associ-
ated with iron starvation and lowered synthesis of iron-containing proteins, and RyjA
(also known as SarL) inhibits the synthesis of trigger factor (a ribosome associated
protein-folding chaperone) in response to lower protein synthesis in stationary phase
(17). Nine sRNAs were signiﬁcantly regulated in the control fermentations, but not in
the test fermentations, postinduction, but these sRNAs were not signiﬁcantly differen-
tially regulated when their abundances in the test fermentations were compared to
those in the controls (Table 3). The 10th sRNA, CsrB, exhibited opposite regulation in
the control and production fermentations, being upregulated in the former and
downregulated in the latter postinduction. The enhanced levels of CsrB should de-
crease the activity of CsrA, which acts as a repressor of gene expression in stationary
phase, consistent with the higher growth rate/yield of the control fermentations (18)
(Fig. 4). More speciﬁcally, CsrA maintains carbon ﬂux toward pyruvate, rather than to
storage as glycogen. Therefore, the decreased abundance of CsrB may increase glyco-
lytic ﬂux beyond the capacity of the pyruvate dehydrogenase complex. This increase in
glycolytic ﬂux would contribute to the observed increase in intracellular pyruvate. An
increase in glycolytic ﬂux might be triggered by a decreased capacity to generate ATP
by oxidative phosphorylation created by the diversion of pyruvate and acetyl-CoA away
from the citric acid cycle toward citramalate production. This diversion likely constrains
the ability to generate reducing equivalents via the tricarboxylic acid (TCA) cycle and
TABLE 2 Operons associated with production of citramalic acid by an E. coli cell factory
that were differentially regulated 2-fold (adjusted P value of 0.05) relative to control
fermentationsa
Gene or operon Function Fold change Direction of regulation
trpLEDCBA Tryptophan biosynthesis 5.1 Up
ygbJK Hypothetical protein 4.1 Down
malK-lamB-malM Maltose transport 3.8 Up
exuT Hexuronate transport 3.6 Down
cysDNC Sulfur metabolism 3.1 Up
cysPUWAM Sulfur metabolism 2.8 Up
fliAZ-tcyJ Flagellar biosynthesis 2.6 Up
aFold change is for the ﬁrst gene in the operon unless indicated otherwise by boldface type.
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subsequently ATP by oxidative phosphorylation. Under such circumstances, lower ATP
availability might invoke increased glycolytic ﬂux, as observed when ATP concentra-
tions are manipulated by expression of an uncoupled ATPase (19).
Two sRNAs (GadY and RprA) were differentially upregulated in the production strain
compared to the control (Fig. 4 and Table 3). Both GadY and RprA sRNAs are associated
with acid tolerance in E. coli (20, 21). GadY increases the stability of the gadXmRNA, and
GadX, along with GadE and RcsB, activates expression of several components of the E.
coli acid response. The E. coli acid ﬁtness island consists of a 12-gene locus that contains
TABLE 3 Differentially regulated sRNA molecules during citramalate production
sRNA Function
Fold change
Preinduction samplesa
Production strain vs
control strainb
CS2 CS3 TS2 TS3 TS2:CS3 TS3:CS3
ChiX Chitosugar catabolism 3.7 1.7 2.5 1.7 NSc NS
CsrB Antagonist of global translational regulator CsrA 3.0 1.3 NS 0.3 0.4 0.2
GadY Acid tolerance—enhances stability of gadX transcript NS NS 1.3 2.1 2.0 3.0
MicF Regulation of OmpF 2.3 1.6 NS NS NS NS
RprA Activation of RpoS-dependent acid tolerance NS NS 1.3 2.5 1.7 2.8
RybA Regulation of TyrR 2.4 1.3 NS NS NS NS
RyeA Possible regulator of OmpD 3.0 1.7 NS NS NS NS
RyfD Overexpression inhibits bioﬁlm formation 2.4 1.3 NS NS NS NS
RygD Unknown 2.6 1.4 NS NS NS NS
RygE Unknown 2.6 1.4 NS NS NS NS
RyhB Iron homeostasis 3.5 1.5 3.3 1.6 NS NS
RyjA Upregulated in intracellular Salmonella 3.1 2.0 2.2 2.1 NS NS
SroC Overexpression inhibits bioﬁlm formation 0.4 0.5 NS NS NS NS
SroG Phantom gene? 2.7 1.4 NS NS NS NS
Tff Probable attenuator of rpsB expression 2.2 1.4 NS NS NS NS
aDifferences in the abundances of the indicated sRNA species relative to the preinduction samples (CS1 and TS1). Only those sRNA species that exhibited 2-fold
change (FDR adjusted P value of 0.05) for one or more samples are shown.
bDifferences in the abundances of the indicated sRNA species in the production strain (TS2 and TS3) relative to those in the control strain (CS2 and CS3). Only those
sRNA species that exhibited 2-fold change (unadjusted P value of 0.05) for one or more comparisons are shown.
cNS, not signiﬁcant.
FIG 4 Responses of the E. coli chassis to production of citramalate. Inference of changes in transcription
factor activities suggested that the activity of GadW decreased upon synthesis of citramalate (Fig. 3B).
Accordingly, the abundance of the GadW-repressed sRNA GadY increased (Table 3). GadY acts to stabilize
the mRNA encoding GadX, which along with GadE activates expression of the gadBC and hdeAB operons
(coding for the glutamate decarboxylase-glutamate:4-aminobutyrate antiporter acid tolerance system
and the periplasmic chaperones [Table 1]). Citramalate synthesis was also associated with enhanced
abundance of the RprA sRNA, which enhances S-dependent acid tolerance by increasing translation of
RpoS (Table 3). The redirection of carbon from biomass to citramalate production resulted in decreased
abundance of the sRNA CsrB, which is an antagonist of the translational regulator CsrA (Table 3). Higher
CsrA activity in the production strain maintains carbon ﬂux toward pyruvate, rather than to storage as
glycogen, thereby enhancing citramalate productivity. Transcription factors are boxed, sRNAs are in bold,
operons are italic, processes are circled, increased abundance is red, and lower abundance is blue.
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the gadE-mdtEF operon that was upregulated in response to citramalate production
(see above). Most of the genes in this island were also upregulated in response to
citramalate, although most did not meet the criteria to be regarded as signiﬁcant (see
Fig. S5 in the supplemental material). Increased osmolarity enhanced RprA-dependent
translation of the rpoS mRNA, and RprA is known to be upregulated when batch
cultures are exposed to acetic, succinic, or itaconic acid (21, 22), suggesting that the
enhanced abundance of RprA observed in the production fermentations may be a
response to citramalate accumulation.
The chassis proteome responds to induction of recombinant protein produc-
tion but is unperturbed by citramalate. To identify changes in the E. coli proteome
in response to heterologous protein production, a label-free quantiﬁcation approach
was used to compare preinduction (CS1) and postinduction (CS2 and CS3) samples
from the control fermentations expressing recombinant CimA3.7dead. Combining CS2
and CS3 revealed that 109 of the 1,413 detected proteins exhibited a change (64
increased, 45 decreased) in abundance postinduction (2-fold change in abundance
relative to CS1; P  0.05) (Fig. 5; Table S1D and Fig. S4). Of the 1,304 proteins that
exhibited no signiﬁcant change, 1,193 of the corresponding transcripts also did not
signiﬁcantly change. Fourteen differentially regulated genes and proteins were corre-
lated (11 upregulated, araG, betB, exuT, gabT, nanE, rspB, uxaB, uxaC, yafV, ycjX, and
ygeA; 3 downregulated, cysD, purM, and pyrI). The enhanced abundance of the arabi-
nose transporter (AraG, 91.4-fold; AraF, 65.4-fold; and AraC, 12.4-fold) was expected in
FIG 5 Heat map representations of changes in the proteomes of control (left) and production (right) strains. The columns show proteins that exhibited
signiﬁcant changes in abundance relative to the preinduction samples (CS1, TS1) and 4 (CS2, TS2) and 21.5 (CS3, TS3) h after induction of CimA3.7dead (control)
or CimA3.7 (production). Red represents increased abundance and blue decreased abundance. Protein identiﬁers are shown on the left.
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response to arabinose-mediated induction of cimA3.7dead expression, resulting in an
95-fold increase in CimA3.7dead protein. A major feature of the transcript proﬁling was
the downregulation of ﬂagellar and chemotaxis genes, but this was not signiﬁcant in
the proteome. In both control and test fermentations, ﬂagellar gene expression was
downregulated after induction, and this is interpreted as a “fermentation” response to
the production of recombinant protein and was not speciﬁc to citramalate production.
Examination of the proteomic data for control and test fermentations showed that the
only motility-related protein that was signiﬁcantly downregulated after induction was
Tar (8.3-fold and 6.2-fold, respectively). Nevertheless, all the other ﬂagellum-related
proteins that were detected exhibited lower abundance after induction (shown as
protein, control fold decrease, test fold decrease: FliC, 2.7, 2.1; FliY, 2.9, 2.0; FlgK, 2.8, 2.7;
FlgH, 2.0, 1.8; Tsr, 5.2, 4.9; CheA, 1.5, none; CheW, 1.2, none) but did not meet the
criteria for statistical signiﬁcance. In addition, not all ﬂagellar proteins were detected in
the proteomic analysis, and so changes in abundances of these could not be estab-
lished. Thus, qualitatively the transcriptomics and proteomics of motility-related pro-
teins are in agreement.
The rspB transcript and the RspA and RspB proteins were upregulated in both
control and production strains upon induction of CimA. Co-overexpression of rspAB
improved recombinant production of a model protein, -galactosidase, by lowering
accumulation of lactone by-products of amino acid metabolism and dysregulation of
homoserine lactone-associated stationary-phase adaptations (23, 24). Thus, similar to
the Ibp response (see below), upregulation of rspAB is likely associated with recombi-
nant protein synthesis and not citramalate production.
Analysis in AmiGO of the 109 signiﬁcantly regulated proteins at CS2 and CS3
indicated signiﬁcant enrichment in uronic acid metabolism (GO:0006063; 23.23-fold;
P  0.006), monocarboxylic acid catabolic processes (GO:0072329; 5.29-fold; P 
0.0137) and organonitrogen compound biosynthesis (GO:1901566; 2.62; P  0.0158).
The test fermentations, which produce both heterologous protein (active CimA3.7)
and a chemical product (citramalate), also showed increased abundance of CimA3.7 (up
to 76-fold), AraF (arabinose uptake), and UxaC and UxuAB (hexauronate catabolism)
among a total of 152 proteins (74 more abundant and 80 less abundant from a total of
1,103 proteins detected; 2-fold; P  0.05) (Fig. 5; Table S1E). Of the 951 proteins that
exhibited no signiﬁcant change, 944 also showed no changes at the level of transcrip-
tion. The regulation of only four genes/proteins was positively correlated (araG, ibpB,
nanE, and rspB).
In the context of recombinant protein production, the 100-fold increased abun-
dances of the heat shock proteins IbpA and IbpB in both the control and test
fermentations is of interest (Table S1D and E) (25). IbpA and IbpB have been also
previously found as components of inclusion bodies formed during recombinant
protein production and can act to stabilize loosely aggregated proteins and facilitate
effective disaggregation by the DnaK and ClpB chaperone systems.
Differences (2-fold, adjusted P value of 0.05) in protein abundance between
samples TS2 and CS2 and TS3 and CS3 after normalization to the respective preinduc-
tion sample CS1 were observed for only ﬁve proteins: Slp (32-fold upregulated), YbjX
(7.5-fold downregulated), OppD (5.4-fold upregulated), DeoA (5-fold upregulated), and
Upp (4.8-fold upregulated) (Table S1F). Interestingly, the slp transcript, which encodes
an outer-membrane-stabilizing protein that accumulates as growth rate decreases (26),
was 3-fold upregulated when TS2 was compared to CS2, with an unadjusted P value
of 0.016. No clear phenotypes have been associated with a slp mutant, which was
unaltered in its resistance to hydrogen peroxide, ethanol, and SDS (26). There is
evidence that Slp is enhanced in response to N limitation and temperature downshift
and that it might be associated with resistance to low pH (27, 28). The relative
upregulation of Slp at both the transcript and protein levels might suggest that this is
a response speciﬁcally associated with citramalate production.
Overall, our data suggest that the chassis proteome is largely “blind” to citramalate
accumulation as most reproducible changes appear related to protein production
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stress and occur under both test and control conditions without citramalate accumu-
lation.
Citramalate production did not alter the chassis lipidome, but strong growth
cycle effects were observed. The lipids present in the chassis (E. coli) membranes
during high-cell density batch fermentation and citramalate production were deter-
mined by liquid chromatography (LC)-MS-MS with positive- and negative-mode heated
electrospray ionization (HESI). In addition, gas chromatography (GC)-MS of fatty acid
methyl esters (FAMES) was used to identify fatty acids present and any changes in the
proportions of cis/trans isomers. LC-MS-MS analysis resulted in 190 peaks by positive ESI
(see Table S3A in the supplemental material) and 41 by negative HESI (Table S3B).
Chassis lipid composition was largely unaffected by production of citramalate but did
change as both fermentations proceeded (Fig. 6A and B). Principal-component analysis
(PCA) showed a separation between the control and test fermentations for the positive-
mode ESI data, but this change was not evident in the negative-mode data set. The
separation observed in the larger positive-mode data set arose from small changes in
numerous lipids (Fig. 6C and D). Nevertheless, a minor increase in cyclopropane fatty
acid content was observed for both fermentations in CS3 and TS3 (Fig. 6E). Although
distinct changes in the E. coli lipidome were observed during the fermentation, these
changes were not responses to citramalate production.
Citramalate excretion is likely to be nonspecific and mediated by several efflux
systems. The test fermentations yielded citramalate in the culture medium at a
concentration of 25 g liter1. As a charged molecule, citramalate secretion was antic-
ipated to require the action of one or more efﬂux pumps. The efﬂux pump genes alaE
and mdtE were upregulated after induction of CimA3.7, the nmpC gene coding for an
outer membrane protein was downregulated, Slp an outer membrane-stabilizing pro-
tein, was signiﬁcantly upregulated in the test fermentation proteome compared to the
controls, and acrA appeared in both test and control fermentations as the gene most
heavily inﬂuenced by MprA in the TFInfer analysis. Therefore, the corresponding mutant
E. coli strains and the parent were transformed with pBAD24-cimA3.7, and small-scale
citramalate production assays were performed using harvested cells. Analysis of the
culture supernatants showed that the extracellular citramalate concentrations were
similar for all strains tested (see Table S4 in the supplemental material). This suggested
that individually acrA, alaE, mdtE, nmpC, and slp were not essential for citramalate
excretion.
It is possible that intracellular concentrations of citramalate result in efﬂux as a result
of low-afﬁnity interactions with multiple transporters. Data for pyruvate excretion by E.
coli were used to assess the likelihood of this suggestion (29). If the steady-state
intracellular-to-extracellular pyruvate ratio of 50:1 (0.16 mM outside, 7.5 mM inside;
dilution rate of 0.1 h1; biomass, 2.5 g liter1) results from a passive and unsaturated
process (i.e., E. coli has no speciﬁc pyruvate efﬂux system), the rate of pyruvate export
(6.4  106mol h1 g1) is equal to k[7.5  103], yielding an export rate constant k
equal to 8.5  104 h1. The maximum rate of citramalate appearance during the
fermentations was 0.3  103mol h1 g1. Using the value for k calculated for
pyruvate, the maximum intracellular concentration of citramalate is estimated to be
300 mM. The total E. coli metabolome concentration has been estimated at 300 mM
(30). Assuming that E. coli is essentially “blind” to citramalate, as implied by the omic
responses, then the percentage of total ion counts for citramalate (40%) suggests that
the intracellular concentration reaches 200 mM, similar to the estimate calculated
above and the measured extracellular citramalate concentration. These analyses sug-
gested that citramalate concentrations inside and outside the cell are similar, which
might be consistent with the operation of mechanosensitive channels opening in
response to increased turgor pressure as the citramalate accumulates in the cytoplasm.
However, citramalate production assays using harvested cells with single and double
mscL and mscS mutations did not lower the extracellular concentration of citramalate,
suggesting that citramalate export probably occurs through promiscuous major facil-
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itator superfamily proteins when the intracellular citramalate concentration reaches
200 mM (Table S4).
Conclusion. Characterization of the stresses experienced by bacterial cell factories
during synthesis of recombinant proteins and chemical products is essential for im-
proving process efﬁciency and designing new bacterial chassis. Many studies have
investigated the potential use of engineered E. coli strains to produce native organic
FIG 6 Lipid composition of the E. coli chassis changes as fermentation proceeds but is unaffected by citramalate
production. Time series ANOVA2 on (A) positive LC-MS-MS intact lipid analysis indicated that the majority of lipid
features changed with time rather than with citramalate production (labeled strain), with a more balanced output
from negative LC-MS-MS data as shown in panel B. PCA indicated a clearer separation between the control strain
(ﬁlled symbols) and production strain (open symbols) in positive mode (C) compared to negative mode (D). For
both strains, there was a clear transition between preinduction (S1, squares) and postinduction (S2, circles; S3,
triangles) samples. (E) Fatty acid methyl ester (FAME) analysis revealed equivalence between production and
control strains, but in both a reciprocal decrease in 18:1n9 (dotted purple lines [ﬁlled symbols, control strain; open
symbols, production strain]) and increase in the cyclopropanated 17:0cyc (solid blue lines [ﬁlled symbols, control
strain; open symbols, production strain]) was observed over time.
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acids (e.g., lactate, malate, and succinate [31]). While high-titer processes for production
of these organic acids have been developed, multiomic analyses of high-cell-density
fed-batch cultures to determine the cellular responses during organic acid production
are relatively few. Such information could be valuable in guiding further process and
strain developments. Here, a comprehensive omic analysis of E. coli fed-batch fermen-
tations for recombinant protein synthesis (CimA3.7dead) and for the production of a
nonnative organic acid, citramalate, revealed minimal effects on gene expression,
metabolism, or lipid composition, thus providing a simple explanation for the excep-
tional product titers and yields. Although it was anticipated that production of citra-
malate would require major rewiring of cellular metabolism rooted in reprogramming
of transcription and consequent changes in the proteome and lipidome, multiomic
analyses revealed that few adaptations were required to permit high production of
citramalate (Fig. 7).
The multiomic analysis of E. coli high-cell-density batch cultures expressing inactive
recombinant CimA3.7dead (20 mg g1 cdw) permitted identiﬁcation of core stress
responses associated with recombinant protein expression (Fig. S1B). Transcriptomic
and proteomic analyses indicated that recombinant protein expression was associated
with downregulation of ﬂagellar genes and induction of the ibpAB-encoded chaper-
ones. It has been shown that induced expression of the ibpAB operon can be a useful
intervention to enhance recombinant protein yields, especially when combined with
other chaperones, such as ClpB (25, 32, 33).
As expected, the postinduction exo- and endo-metabolite proﬁles of the production
strain were dominated by citramalate. Two minor by-products, citraconate and
2-ethylmalate, were detected at concentrations that would not warrant further inter-
vention to eliminate their presence. During citramalate production, the transcript,
protein, and lipid proﬁling indicated that the level of stress imposed on the E. coli
chassis was low, but some responses were detected that could be attributed to the
citramalate synthesis, including roles for sRNA molecules in maintaining carbon ﬂux
through glycolysis (CsrB) and in acid tolerance (GadY and RprA). Optimizing these sRNA
responses could represent a possible intervention to further enhance citramalate yields.
The analyses of citramalate production reported here suggest that E. coli is a robust
chassis organism and is likely to be an excellent choice for production of other organic
acids.
MATERIALS AND METHODS
Growth media. Escherichia coli strains were grown in either LB (Melford, United Kingdom), SM or ML
media at 37°C. ML medium (1 liter) contained MgSO4·7H2O (2 ml; 246.47 g liter1), salt solution (200 ml)
containing K2HPO4 (73 g liter1), NaH2PO4·2H2O (18 g liter1), (NH4)2SO4 (10 g liter1), ammonium citrate
(2.5 g liter1), trace elements (2 ml) containing Na2EDTA·2H2O (22.3 g liter1), FeCl3 (10.03 g liter1),
FIG 7 Schematic highlighting the key ﬁndings of this work. Overexpression of CimA3.7 (test, ﬁlled
squares) or CimA3.7dead (control, open squares) resulted in a downregulation of ﬂagellar synthesis. The
test fermentation overexpressing CimA3.7 produces citramalate (blue circles) in addition to the normal
metabolome (multicolored circles), but at the expense of an equivalent amount of biomass production.
Citramalate is exported through an undetermined route (arrows).
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CaCl2·2H2O (0.5 g liter1), ZnSO4·7H2O (0.18 g liter1), CoCl2·6H2O (0.18 g liter1), CuSO4·5H2O (0.16 g
liter1), and MnSO4·H2O (0.15 g liter1) and glucose (the concentration of which, as indicated in the text,
was added from a sterile stock solution at 250 g liter1). When required, carbenicillin was added to the
medium at a concentration of 50 mg liter1. Polypropylene glycol (0.1 ml liter1) was added to the
medium when used in a fermentor. The SM medium (1 liter [34]) contained glycerol (30 ml; 500 g liter1),
yeast extract (50 ml; 100 g liter1), MgSO4 (2 ml; 246.47 g liter1), salt solution (200 ml) containing
Na2HPO4·12H2O (75.6 g liter1), KH2PO4 (15 g liter1), NH4Cl (5 g liter1), NaCl (2.5 g liter1), CaCl2 (55 mg
liter1), and SM trace element solution (100 l) containing FeSO4·7H2O (80 g liter1), AlCl3·6H2O (10 g
liter1), MnSO4·H2O (10 g liter1), CoCl2 (4 g liter1), ZnSO4·7H2O (2 g liter1), Na2MoO4·2H2O (2 g liter1),
CuCl2·2H2O (1 g liter1), and H3BO3 (0.5 g liter1) dissolved in HCl (3 M). Glycerol, yeast extract,
MgSO4·7H2O and salt solutions were prepared and autoclaved separately. Trace elements were sterilized
by ﬁltration using 0.2-m-pore ﬁlters. All solutions were cooled before mixing.
Preparation of E. coli strains. Escherichia coli BW25113 and E. coli BW25113 ldhA were purchased
from the Keio collection (35). A control plasmid (pBAD-cimA3.7dead) expressing an inactivated CimA3.7 by
virtue of a His192Ala substitution was constructed using Quickchange II XL site-directed mutagenesis kit
(Agilent Technologies). The manufacturer’s protocol was followed with primers (5=-ACCTGCCGGTTAGC
GTGGCCTGCCATAACGATTTCGGC-3= and 5=-GCCGAAATCGTTATGGCAGGCCACGCTAACCGGCAGGT-3=) and
pBAD-cimA3.7 (5) as the template. Electro-competent E. coli BW25113 ldhA was transformed to create
strains expressing active or inactive CimA; transformants were selected on LB agar supplemented with
carbenicillin (50 mg liter1). Escherichia coli BW25113 ldhA was used in the fermentation processes to
minimize lactate formation based on unpublished results (J. Webb, personal communication). Other E.
coli BW25113 mutants were also obtained from the Keio collection, except themscL mscS double mutant,
which was constructed using pCP20 (36) to cure the kanamycin cassette from E. coli BW25113mscL::Kanr,
followed by deletion of mscS from the resulting strain (E. coli BW25113 mscL::FRT) by P1 transduction of
the mscL mutation from E. coli BW25113 mscL::Kanr.
Citramalate production using harvested cells. Single colonies of E. coli BW25113 ldhA expressing
either active or inactive CimA3.7 were grown overnight (37°C, 250 rpm) in SM glycerol medium. Cultures
were diluted to a starting OD600 of 0.1 in SM glycerol medium, and the culture was incubated (250 rpm,
37°C) until the OD600 reached 0.6. CimA3.7 expression was induced by the addition of L-arabinose (0.2 g
liter1). Cells were harvested by centrifugation (4,000  g, 20 min, 4°C) 4 h postinduction (OD600 of 3 to
4) and concentrated to a dry cell weight of 15 g liter1 in SM medium without NH4Cl or yeast extract but
with glucose (20 g liter1). The cell suspensions (approximately 10 ml) were incubated in bafﬂed ﬂasks
(250 ml, 24 h, 250 rpm, 37°C) before analysis of culture supernatants by high-pressure liquid chromatog-
raphy (HPLC).
Fermentations. Inocula for fed-batch fermentations were produced by inoculating E. coli BW25113
ldhA pBAD24-cimA3.7 or E. coli BW25113 ldhA pBAD24-cimA3.7dead into ML medium (50 ml) supple-
mented with glucose (10 g liter1) and carbenicillin (50 g ml1) and incubating overnight (200 rpm,
37°C). The cultures were diluted to OD600 of 0.1 in sterile water (50 ml) and used to inoculate ML medium
(1 liter) supplemented with glucose (11.9 g liter1) and carbenicillin in a 3-liter BioFlo/CelliGen 115
bioreactor (New Brunswick Scientiﬁc). Cultures were grown at 37°C, and the pH was maintained at
7.0  0.1 by the addition of NH4OH (28 to 30%) and 2 M H2SO4 (2 M). The airﬂow rate was initially set at
1 liter min1, and the dissolved oxygen (dO2) was maintained at 30% of saturation by automatic control
of stirrer speed between 400 and 1,200 rpm and an airﬂow cascade between 1 and 7 liter min1. The
airﬂow cascade was only implemented when maximum agitation was reached. Drops of polypropylene
glycol (100%) were manually added to the medium when required to avoid foaming. When the glucose
in the batch medium had been consumed, indicated by a sharp increase in dO2 and conﬁrmed using
glucose test strips (117866; Merck Millipore), a feed of glucose was started containing glucose (650 g
liter1), yeast extract (5.9 g liter1), MgSO4 (7.2 g liter1), and trace elements (11.8 ml). The ﬂow rate was
adjusted manually as required to maintain a pseudoexponential growth rate of approximately 0.25 h1
and avoid the accumulation of excess glucose in the culture, using the test strips as conﬁrmation as
described above. Protein expression was induced by the addition of L-arabinose (0.02% wt/vol) when the
culture OD600 was 50.
Analytical methods. Growth was monitored by measuring OD600. Samples were diluted in deionized
water when the OD600 was 0.8. Dry cell weight was measured by centrifuging 1-ml samples in
preweighed polypropylene tubes, removing the supernatant, and drying the pellets to a constant weight.
D-Glucose, (R)-citramalate, and other organic acids were quantiﬁed by HPLC using an Agilent 1200 series
HPLC system equipped with both UV (215 nm) and refractive index detectors. Samples were resolved
using a Rezex ROA organic acid H	 column (Phenomenex) at 55°C with 0.01 N H2SO4 (0.5 ml min1) as
the mobile phase. Samples were prepared for HPLC analysis by centrifuging (12,000  g, 5 min) and
ﬁltering the supernatants (0.2-m-pore ﬁlter). Data analysis was performed with ChemStation software
using calibration curves prepared using authentic standards of each compound (0.1 to 200 mM).
Transcriptomics. Fermentation samples (3  0.1 ml) were mixed with RNAprotect (Qiagen [0.2 ml]),
vortexed, and incubated at room temperature (5 min). The mixture was then centrifuged (16,000  g,
2.5 min, 4°C) and the supernatant discarded, and pellets were stored at 80°C. Cell pellets were thawed
at room temperature and normalized in TE buffer (10 mM Tris-HCl at pH 8.0, 0.1 mM EDTA), such that 1 ml
of TE buffer contained 2 OD600 units. Aliquots (1 ml) were harvested by centrifugation (12,000  g, 1 min),
and the pellets were resuspended in 100 l TE buffer containing lysozyme (15 mg ml1). These were
incubated at room temperature (10 min) with vortexing every 2 min. Total RNA was prepared using the
RNeasy RNA puriﬁcation kit (Qiagen) according to the manufacturer’s protocol (including the on-column
DNase treatment step). Labeled cDNA was produced using SuperScriptIII reverse transcriptase (Invitro-
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gen) with the Cy3-dCTP included in the dNTP mixture. Labeled E. coli genomic DNA was produced using
the BioPrime DNA labeling kit (Invitrogen) with Cy5-dCTP included in the dNTP mixture. Labeled
genomic DNA and cDNA were combined and hybridized overnight to an oligonucleotide microarray
(Agilent Technologies). Quantiﬁcation of cDNA, hybridization of cDNA to microarrays, microarray pro-
cessing, and microarray scanning were performed as described in the Fairplay III labeling kit (Agilent
Technologies, 252009, version 1.1). Microarrays were scanned with a high-resolution microarray scanner
(Agilent Technologies). Features with background intensities exceeding 10 times the array median, or
with a signal/background ratio below 3 were excluded from further analysis. Background correction (37),
within-array Loess normalization (38), and between-array quantile normalization were applied to the
remaining features using the R statistical package LIMMA from Bioconductor (39). Moderated t statistics
were calculated using gene-wise linear models with an empirical Bayes approach (40, 41). P values were
adjusted for multiple testing using the Benjamini-Hochberg method (42). Transcripts exhibiting 2-fold
change in abundance with an adjusted P value of 0.05 were deemed to be differentially regulated. The
data are available in ArrayExpress. The relative activities of transcription factors were inferred using the
TFInfer software package as previously described (14).
Metabolomics. Quenching of fermentation samples (0.5 ml) was performed by mixing ethanol
solution (40% vol/vol) prepared in NaCl (0.8% wt/vol) at 20°C (43). The mixture was centrifuged
(16,000  g, 2.5 min, 4°C). The supernatant was discarded, and the pellets were stored (80°C) until
required. Cell pellets were resuspended to an OD600 of 1 in chloroform-methanol (1:1, 20°C), and 1 ml
was transferred to a fresh polypropylene tube. An ice-cold ball bearing was added to each tube before
incubation (80°C, 1 h). The samples were then vortexed twice (30 s) and returned to the 80°C freezer
for 1 h. Milli-Q water (400 l) was added to each sample, followed by vortex mixing (30 s). Samples were
then centrifuged (4,000  g, 1 min, 4°C). The upper layer was transferred to a fresh tube. This step was
repeated, and the two organic phases were combined. Electrospray ionization time-of-ﬂight (ESI-TOF) MS
was performed on a Hybrid quadrupole time-of-ﬂight (TOF) LC-MS-MS spectrometer (Waters, Ltd.,
Manchester, United Kingdom) based on the methods described by Davey et al. (44) and Walker (45). Data
acquisition and processing were performed on MassLynx (version 4) to create centroid peak lists (m/z
accurate to 4 decimal places versus ion counts), which were then transferred to Microsoft Excel (Microsoft
Corp., USA) as text ﬁles. The mass spectrometer was operated in negative-ion mode at a rate of 1 scan
per s for 6 min. Samples were loaded using a syringe pump (Razel, CT, USA) at a ﬂow rate of 20 l min1.
A Lockspray interface was used to give an external standard and allow automated correction of mass
measurements (5 ng liter1 sulfadimethoxine, giving a lock mass of 309.0653). Samples were analyzed in
a randomized order to minimize effects of day-to-day machine variation. Data processing and down-
stream analysis were performed in R, using Bioconductor package XCMS (46). Peaks were aligned across
analytical replicates and grouped into 0.2-m/z-width bins (47). Peaks were rejected if all three replicates
were not present or the mass variance fell outside an acceptable range deﬁned as a function of the m/z
(formula modiﬁed from Overy et al. [48]; H. Walker, personal communication).
Proteomics. (i) Protein extraction and peptide sample preparation. Fermentation samples
(500 l) were harvested by centrifugation (16,000  g, 2.5 min, 4°C). The supernatant was discarded and
the pellet stored (80°C). Cells were embedded in a 20% polyacrylamide gel matrix and digested and
washed following the gel-aided sample preparation (GASP) protocol with three minor changes (49). First,
samples were reduced using 10 mM Tris(2-carboxyethyl)phosphine (TCEP); second, they were desalted
after gel extraction on Sola C18 cartridges following the manufacturer’s instructions; third, after the
samples were dried to near dryness, they were resuspended in 0.1% formic acid for injection into the
mass spectrometry-liquid chromatography system. Injections were normalized by a quantitative colori-
metric assay (Thermo) that uses a modiﬁed bicinchoninic acid (BCA) chemistry for sensitive and accurate
peptide sample quantiﬁcation to keep samples comparable and to optimize signal intensity.
The buffers used for the GASP method were as follows. Lysis was performed on ice (30 min) in a
buffer containing urea (6 M), thiourea (1.5 M), SDS (4%), TCEP (10 mM), 20 mM Tris (20 mM, pH 8.0).
Alkylation was achieved on ice (30 min) using an equal volume of monomeric acrylamide mix solution
(40%, 37.5:1 acrylamide-bisacrylamide solution). Polymerization was initiated at room temperature by
addition of N,N,N=,N=-tetramethylethylenediamine (TEMED [5 l]) and ammonium persulfate (APS [10%])
followed by rapid mixing by vortexing. After polymerization was complete (30 min), gel plugs were cut
by centrifugation through a membrane-less SpinX centrifugation ﬁlter support device (Costar) to achieve
identical sizes of gel pieces. Gel pieces were ﬁxed by addition of ﬁxation buffer (1 ml) containing
methanol-acetic acid-water (50:40:10) and overhead rotation (10 min). After brief pulse centrifugation,
the supernatant was discarded and gel pieces were rehydrated with urea (6 M, 0.5 ml, 10 min). Aceto-
nitrile (1 ml) was used to dehydrate gel pieces. Following removal of the supernatant using a gel loading
pipette tip (200-l-volume pipette tip with a long narrow end to avoid loss of gel pieces), two more
rounds of urea and acetonitrile washes were performed to minimize carryover of SDS and other
contaminants. After these washes, the gel pieces were pH adjusted using triethylammonium bicarbonate
(TEAB [500 l, 50 mM, pH 8.0]) and rotation (10 min). Gel pieces were dehydrated once more using
acetonitrile (1 ml), supernatant was removed, and acetonitrile (0.5 ml) was used for more thorough
dehydration of the gel pieces. Dried-out gel pieces were soaked with trypsin solution (1/50 enzyme/
substrate ratio based on expected protein content from known cell mass in Tris buffer [20 mM, pH 8.0]).
Digestion was performed overnight with shaking (1,000 rpm, 37°C). Elutions were performed using one
gel volume: elution 1 with acetonitrile, 2 with formic acid (5%), and 3 with acetonitrile. Elutions 2 and 3
were combined.
(ii) Mass spectrometry analysis. Peptides (1 g) from each label-free sample were injected and
separated via 1D-ultrahigh-pressure liquid chromatography (UHPLC) using a Dionex Ultimate 3000 RSLC
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nanoUPLC (Thermo Fisher Scientiﬁc, Inc., Waltham, MA, USA) system, and masses were analyzed using an
Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientiﬁc, Inc., Waltham, MA, USA). Separation
of peptides was performed by reverse-phase chromatography at a ﬂow rate of 300 nl min1 on a Thermo
Scientiﬁc reverse-phase nano-Easy-spray column (Thermo Scientiﬁc PepMap C18, 2-m particle size,
100-Å pore size, 75-m inside diameter [i.d.] by 50-cm length). Peptides were loaded onto a precolumn
(Thermo Scientiﬁc PepMap 100 C18, 5-m particle size, 100-Å pore size, 300-m i.d. by 5-mm length) from
the Ultimate 3000 autosampler with formic acid (0.1%) for 3 min at a ﬂow rate of 10 l min1. After this
period, the column valve was switched to allow elution of peptides from the precolumn onto the
analytical column. Solvent A was H2O containing formic acid (0.1%), and solvent B was acetonitrile (80%),
H2O (20%), and formic acid (0.1%). The linear gradient employed was 2 to 45% B in 90 min. The total run
time was 120 min, including a high-organic-wash step and reequilibration step. Peptides were transferred
to the gaseous phase with positive-ion electrospray ionization at 2.1 kV. In DDA, the top 20 precursors
were acquired between 360 and 1,500m/z with a 1.5-Th (Thomson) selection window, dynamic exclusion
of 35 s, normalized collision energy (NCE) of 30%, and resolutions of 70,000 for MS and 17,500 for MS2;
the automatic gain control (AGC) target was 500,000. The .raw ﬁles were analyzed with MaxQuant version
1.5.5.1 using default settings. The minimal peptide length was set to 6. Trypsin/P was used as the
digestion enzyme. Search criteria included propionamidation of cysteine (PAM-Cys [	71.0371 Da]) as a
ﬁxed modiﬁcation and oxidation of methionine and acetyl (protein N terminus) as variable modiﬁcations.
Up to two missed cleavages were allowed. The mass tolerances for the precursor were 20 and 4.5 ppm
for the ﬁrst and the main searches, respectively, and that for the fragment ions was 20 ppm. The ﬁles
were searched against the E. coli K-12 reference UniProt fasta database (July 2017 [4,306 sequences]). The
identiﬁcations were ﬁltered to obtain a false-discovery rate (FDR) of 1% at the peptide and the protein
levels. No ﬁlter was applied to the number of peptides per protein. Log2-transformed quantiﬁcation
results were tested for differential abundance using moderated t statistics using the LIMMA R package.
The mass spectrometry proteomics data have been deposited into the ProteomeXchange Consortium via
the PRIDE partner repository (50).
Lipidomics. Fermentation samples (500 l) were harvested by centrifugation (16,000  g, 2.5 min,
4°C), and the supernatants were discarded. The pellet was washed twice in a salt solution consisting of
(NH4)SO4 (2 g liter1), K2HPO4 (14.6 g liter1), NaH2PO4·2H2O (3.6 g liter1), and (NH4)2citrate (0.5 g
liter1). Samples were lyophilized, and 4 mg was transferred into 2-ml microcentrifuge tubes for lipid
extraction. All solvents were HPLC grade from Rathburn Chemicals (Walkerburn, Scotland, United
Kingdom). Lipids were extracted by adding isopropanol (400 l) and a deuterated internal standard mix
(10 l SPLASH lipidomix, p/n 330707; Avanti Polar Lipids, AL, USA). Samples were brieﬂy resuspended
with a micropestle, and the tubes were capped and incubated (95°C, 15 min) to inactivate phospho-
lipases. Samples were cooled (4°C) before adding hexane (600 l), followed by brief vortex mixing and
centrifuging (16,000  g, 10 min). The supernatant was transferred to a fresh tube and aqueous Na2SO4
(500 l, 6.7% wt/vol) added to promote phase separation. The tubes were brieﬂy vortexed and centri-
fuged to separate the layers, and the organic (top) layer (200 l) removed to a glass HPLC vial for LC-MS
analysis of intact lipids. A separate aliquot (200 l) was kept for transmethylation to fatty acid methyl
esters (FAMEs) for analysis by GC-MS. All samples were dried on a centrifugal evaporator. Technical
triplicates were extracted from each fermentor at each time point, and extraction blanks were processed
in parallel to correct for any background contamination in subsequent analyses.
For GC-MS analysis, FAMEs were generated by incubating dried samples with 1 N methanolic HCl
(Supelco) in sealed glass vials (85°C, 4 h). Samples were cooled before adding hexane (200 l) and
aqueous KCl (250 l 0.9%), vortexing and centrifuging brieﬂy, and collecting the upper phase (100 l) for
analysis. GC-MS analysis of FAMEs was performed using an Agilent 6890 gas chromatograph interfaced
with a Leco Pegasus IV TOF MS (Leco, Stockport, United Kingdom) system. Data acquisition and
processing was performed using ChromaTof 4.5 software (Leco). A 1-l aliquot was injected in pulsed
splitless mode onto an Rxi-5Sil MS column (30-m by 0.25-mm i.d. by 0.25-m ﬁlm thickness; Thames
Restek, Saunderton, United Kingdom). FAMEs were separated in He at a constant ﬂow of 1 ml min1
under the following conditions: initial 100°C for 2 min, linear ramp at 5°C min1 to 300°C, hold at 300°C
for 2 min, and total run time of 44 min. EI spectra were obtained at 70 eV at a detector voltage of
1,790 V, at a rate 5 spectra s1 over the m/z range 50 to 450. ChromaTof was used to detect peaks at a
minimum s/n of 10 and peak width of 3 s, and peak areas were reported from deconvoluted total-ion
chromatograms. Peaks were identiﬁed by searching electron ionization (EI) spectra against the NIST 2014
library and comparing retention times and spectra to a bacterial FAME reference mix (Larodan, Sweden).
For LC-MS analysis, samples were reconstituted in acetonitrile-isopropanol (200 l, 70:30 vol/vol). LC
was achieved using a Waters Acquity I-Class UPLC system, ﬁtted with an Accucore C30 column (Thermo
Scientiﬁc [100 mm by 2.1 mm, 2.6-m particle size]). The column was protected with an Accucore C30
guard cartridge (10 mm by 2.1 mm). Samples were chilled (10°C) in the UPLC autosampler, and a 2-l
aliquot was injected. The weak wash solvent was methanol (5% vol/vol), and the strong wash solvent was
isopropanol. For sample elution, the mobile phase A was acetonitrile-water (60:40 vol/vol) plus ammo-
nium formate (10 mM) plus formic acid (0.1% vol/vol). Mobile phase B was acetonitrile-isopropanol (10:90
vol/vol) plus ammonium formate (10 mM) plus formic acid (0.1% vol/vol). Lipids were eluted at 0.35 ml
min1 and 40°C, using the following gradient: initial 1% B, linear increase to 99% B at 21 min, hold at 99%
B until 24 min, return to initial conditions at 24.1 min, and hold at initial conditions until 28 min. Mass
spectra were acquired using a Thermo Orbitrap Fusion Tribrid mass spectrometer, ﬁtted with a heated
electrospray ionization (HESI) ion source. The UPLC and MS were controlled by Thermo Xcalibur 4.0
software. Alternate injections were made in positive- and negative-ion acquisition modes. In positive
mode, the spray voltage was set to 3,500 V, and in negative mode, it was set to 3,000 V. In both modes,
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nitrogen gas ﬂows for sheath, auxiliary, and sweep gases were set to 42, 14, and 1 arbitrary unit,
respectively. The ion transfer tube was set to 300°C and the HESI vaporizer to 280°C. Data were acquired
in a set 1-s cycle time, with high resolution (240,000 full width at half-maximum [FWHM] at m/z 200) MS1
proﬁle spectra acquired over the m/z 200 to 1,600 scan range, with an AGC target of 200,000 and a
maximum ion injection time of 100 ms. MS1 data were internally calibrated during acquisition to
1-ppmmass error using the installed Thermo Easy IC option. Data-dependent MS2 scans were collected
in parallel using a 1-m/z quadrupole isolation window and scanned at approximate unit mass resolution
in centroid mode from the ion trap, alternating between higher-energy collisional dissociation (HCD) and
collision-induced dissociation (CID) fragmentation modes. Only MS1 masses of 400m/z were selected
for fragmentation, with an AGC target of 10,000 and max ion time of 50 ms. HCD spectra were collected
in stepped collision energy mode centered at 40% and CID spectra at a ﬁxed 40%. Dynamic exclusion was
enabled, with exclusion after n  1 times, for 6 s.
For analysis of LC-MS-MS data, Xcalibur .raw ﬁles were converted to centroided. mzML format using
the msconvert function of ProteoWizard (release 3.0.18114). Peak processing workﬂows were conducted
in R 3.5.0. MS1 peaks were extracted using the “centWaveWithPredictedIsotopeROIs” method from the
XCMS package (version 3.2.0 [46, 51]). Peaks were grouped across samples, missing peaks imputed by
reintegration within group boundaries, and group median m/z values further processed using the
CAMERA package (version 1.23.3 [52]), to identify isotopes and adducts. Candidate formulas were
generated with adapted code from the rcdk package (version 3.4.9 [53]), with the following limits:
positive mode, C10-300, H20-500, O0-20, N0-3, P0-2, Na02, RDBE 0.5-18, 2-ppm error; negative mode,
C10-300, H20-500, O0-20, N0-3, P0-2, S0-2, RDBE 0.5-18, 20-ppm error. Consensus peak groups were
then ﬁltered with custom R scripts to (i) exclude any peak groups where any peak in the group was
present with an area less than the mean 	 3 standard deviations of the value from blank extracts, (ii) only
retain the most intense monoisotopic peak identiﬁed by CAMERA, and (iii) only retain peaks with valid
molecular formulas. MS1 peaks were searched against downloaded local copies of the E. colimetabolome
database (ECMDB [54]) and the Lipid Maps Structure Database (LMSD [http://www.lipidmaps.org]).
Consensus HCD and CID MS2 spectra were extracted with custom scripts and searched against the in
silico LipidBlast (55) and LipidMatch (56) databases. Peaks were annotated following manual examination
of MS2 spectra in consensus with returned database hits. All retained peaks were normalized to the
SPLASH deuterated PC [15:0_18:1(d7)] internal standard and then to sample dry weight. Statistical
analyses were carried out on glog normalized data (lambda value in glog transform taken to be 1/10 of
nonzero minimum), using time-series ANOVA2 models from the online MetaboAnalyst resource (https://
www.metaboanalyst.ca).
Citramalate synthase assay. Cell-free extracts of E. coli BW25113 ldhA pBAD24-cimA3.7, E. coli
BW25113 ldhA pBAD24-cimA3.7Adead or E. coli BW25113 ldhA were prepared from cultures (400 ml) 4 h
after induction with L-arabinose (0.02 g liter1). Cells were harvested by centrifugation (8,000  g, 10 min,
4°C) and resuspended in HEPES buffer (0.1 M, pH 7.5) containing MgCl2 (5 mM). Cells were lysed by three
passages through a French pressure cell. The resulting cell suspension was centrifuged (12,000  g,
10 min), and the supernatant containing the soluble protein was ﬁltered (0.2-m-pore ﬁlter). Total
protein concentration was estimated using a Bio-Rad protein assay as described by the manufacturer,
and the protein content was normalized to 1 mg ml1 in HEPES buffer (0.1 M, pH 7.5) containing MgCl2
(5 mM). CimA3.7 and CimA3.7dead were assayed using a modiﬁed method described by Howell et al. (57).
The enzyme assay mixture (1 ml) contained acetyl-CoA (1 mM), pyruvate (1 mM), cell extract (200 l), and
HEPES buffer (0.1 M, pH 7.5) containing MgCl2 (5 mM). The reaction mixture was incubated at 37°C, and
at regular intervals (10 min), samples (100 l) were taken and mixed with a sample analysis mixture
(900 l), and the absorbance at 412 nm was measured. The sample analysis mixture (900 l) contained
5,5=-dithio-bis-(2-nitrobenzoic acid) (DTNB [0.56 mM]), Tris-HCl (78 mM, pH 8.0), and distilled water
(dH2O). Where indicated in the text, pyruvate was replaced by 2-oxobutyrate.
Data availability. Transcriptomics data are available in ArrayExpress under accession no. E-MTAB-
7257. The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consor-
tium database via the PRIDE partner repository under accession no. PXD013088 (50).
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